Eric Blossey

Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world.

EndoChoice, Inc. operates as a medtech company which focuses on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices, and infection control products and pathology services. Its imaging systems include fuse endoscopy system, fuse accesories, carts, cart options, monitors, monitor cart mounts, monito wall mounts, scope services, and suction pumps and supplies. Its devices include band ligators, biopsy forceps, bipolar probes, bite blocks, cytology brushes, electrosurgical supplies, metal stents, needles, retrieval devices, and snares. The company was founded by Mark G. Gilreath and William Parks in 2007 and is headquartered in Alpharetta, GA.

Viant Group LLC provides investment and financial advisory services. It offers mergers and acquisitions, raising capital, valuation and advisory, and viant green capital. The company was founded by Scott Smith in 1998 and is headquartered in San Francisco, CA.

Clinical Innovations LLC develops, manufactures and markets medical devices. It products include traxi Panniculus Retractor, ROM Plus Rupture of Membranes Test, ebb Complete Tamponade System, Koala Toco, Kiwi Complete Vacuum Delivery System, Koala IUPC, ClearView Uterine Manipulator and C-Snorkel Impacted Fetal Head Release. The company was founded in 1993 and is headquartered in Murray, UT.

Credit Suisse Securities (USA) LLC provides a variety of capital raising, market making, advisory and brokerage services for governments, financial institutions, high-net-worth individuals, and corporate clients and affiliates. It is also a primary dealer in U.S. government securities and an underwriter, placement agent, and dealer for money market instruments, commercial paper, mortgage and other assetbacked securities, as well as a range of debt, equity and other convertible securities of corporations and other issuers. The company was founded on January 3, 2003 and is headquartered in New York, NY.

Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million.

North American Spine Society engages in the provision of education, research, and advocacy on spine care for patients. The company is headquartered in Burr Ridge, IL.

LaVecchia Capital LLC engages in brokerage industry. The firm focuses on buying and selling securities such as stocks, bonds, and mutual funds. The company was founded is headquartered in Darien, CT.

Part of Hovnanian Enterprises, Inc., Traverse Partners LLC provides investment advice. The company is based in Mooresville, NC. The company was founded by Jeff Janer.

Tiburon Holdings LLC is an investment holding private company. The company is based in New York, NY.

Firefly Medical, Inc. develops and produces transformative patient mobility solutions. It offers IVEA, a flagship product that solves multiple problems around patient ambulation in the acute-care setting. The company was founded by Steve Schmutzer in 2013 and is headquartered in Fort Collins, CO.

Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019.

Oasis Pro Markets LLC is a fintech and blockchain company that aims to bridge the gap between traditional finance, blockchain, and decentralized finance. The company is based in Darien, CT. Pasquale M. LaVecchia has been the CEO of the company since 2008. The company's subsidiary, Oasis Pro Market, is a FINRA member firm that operates a multi-asset ATS called OATSPro, which allows primary issuance and trading of public and private multi-asset digital securities. The platform enables subscribers to buy, sell, and offer a range of alternative assets in the secondary market, and make payments for digital securities via fiat and digital currencies. Oasis Pro Markets is the first US-regulated trading system authorized to allow subscribers to trade digital securities for digital cash.